Team
Richard D. Batson, ND, MSc. (Endocrinology), Dipl.(Endo)
Cofounder, Executive Director, Clinician, Director of Forensics, Forensic Consultant & Expert Witness
Richard D. Batson is the executive director and co-founder of Neurevolution Medicine, PLLC. His clinical practice focuses on traumatic brain injury evaluation and rehabilitation with a specialization in traumatic brain injury-related pituitary dysfunction.
Dr. Batson completed his Master of Science in Clinical Endocrinology with distinction with a postgraduate dissertation in the area of post-traumatic hypopituitarism (PTHP), also referred to as TBI-related neuroendocrine dysfunction, or TBI-related pituitary dysfunction. PTHP is a group of endocrine disorders that evolve in some individuals following traumatic brain injury and results in select or multiple hormonal deficiencies. He works clinically with the TBI population with a focus on evaluation and treatment of PTHP.
In addition, Dr. Batson is a member of the Brain Injury Associated Fatigue and Altered Cognition (BIAFAC) research group at the University of Texas Medical Branch (UTMB) which conducts research on the connection between traumatic brain injury, growth hormone dysregulation, and the gut microbiome. He is also a research investigator, and the director of neurotrauma education for the NIH-funded Neurotrauma Evidence Synthesis Training (NEST) at Helfgott Research Institute. He is president and founder of the Endocrine Brain Injury Research Alliance, SPC, a social purpose corporation dedicated to exploring the long-term consequences and outcomes of traumatic brain injury, including the neuroendocrine sequelae of brain injury, as well as the best available treatments and methods of rehabilitation.
His areas of research and publications include, but are not limited to:
- Post-traumatic hypopituitarism (PTHP)
- Growth Hormone Deficiency following Mild TBI
- Brain Injury Fatigue and Altered Cognition (BIAFAC)
- Advanced Neuroimaging in Traumatic Brain Injury
- Post-traumatic Epilepsy
- Convergence Insufficiency after TBI
- Quality of Life outcomes with Recombinant Growth Hormone Treatment
- Comparison of IGF-1 Assays in the Assessment of Growth Hormone Deficiency
- Post-acute COVID-19
- Cognition and the Microbiome
In addition, he is an adjunct peer-reviewer for Biofactors, Cardiovascular Endocrinology & Metabolism, Current Medical Research & Opinion, Diabetes Therapy, Endocrine Practice, Endocrine Reviews, European Journal of Endocrinology, Growth Hormone & IGF-1 Research, Journal of Clinical Endocrinology & Metabolism, Journal of Clinical Medicine, Journal of the Endocrine Society, and Pituitary and has also been an invited peer-reviewer for the Journal of Alzheimer's Disease.
*Dr. Batson does not prescribe hormonal therapies for anti-aging , cosmetic purposes, or for athletic performance.
Cyrus Raji, MD, PhD | Neuroradiology
Scientific Advisor, Forensic Consultant & Expert Witness
Cyrus A. Raji, MD, PhD is a tenured associate professor of radiology and neurology as well as a principal investigator in the Neuroimaging Labs Research Center at Mallinckrodt Institute of Radiology (MIR), the academic radiology department of Washington University School of Medicine in St. Louis. In addition, he directs the Raji Brain Health Imaging Lab. Additionally, he serves as director of Neuromagnetic Resonance Imaging at Barnes-Jewish Hospital and as associate director of the diagnostic radiology residency research track.
Dr. Raji obtained his MD and PhD degrees from the University of Pittsburgh School of Medicine where he was part of pioneering work on the application of amyloid imaging in Alzheimer’s disease. He then did his internship at UPMC-Mercy Hospital before doing a four-year diagnostic radiology residency at UCLA Medical Center where his research won the Radiological Society of North America Roentgen Award for Outstanding Radiological Research. He then completed a two year Neuroradiology fellowship at UCSF that included an NIH funded research year on diffusion MRI in traumatic brain injury.
Dr. Raji is board-certified in diagnostic radiology and neuroradiology with research interests focusing on modifiable risk factors for dementia and the role of advanced neuroimaging in quantitatively tracking related brain changes and identifying traumatic brain injury. He has published over 100 peer-reviewed articles on advanced neuroimaging, including in traumatic brain injury and has been cited over 6,000 times. His NIH funded research has been featured multiple media outlets including CNN, Fox News, the New York Times and USA Today. Dr. Raji is also recognized as a 2024 Castle Connelly Top Doctor in Neuroradiology, MRI, and traumatic brain injury. Dr. Raji has played an instrumental role in ensuring that advanced imaging techniques are admissible in court and his work has been featured in the National Law Review, consistent with the AMA Code of Medical Ethics mandate that physicians with specialized knowledge have an obligation to assist in the administration of justice.
Matthew Brier, MD, PhD | Neurology
Forensic Consultant & Expert Witness
Matthew R. Brier, MD, PhD, is a board-certified neurologist and Assistant Professor in the Neuroimmunology/Multiple Sclerosis section within the Department of Neurology at Washington University School of Medicine in St. Louis. He is also affiliated with Barnes-Jewish Hospital, where he provides expert clinical care to patients with neuroinflammatory disorders, particularly multiple sclerosis (MS). His dual roles in clinical practice and translational research place him at the forefront of efforts to improve outcomes for individuals affected by complex neurologic disease.
Dr. Brier completed his undergraduate studies in neuroscience at the University of Texas at Dallas and earned both his MD and PhD through the prestigious Medical Scientist Training Program at Washington University. His doctoral research, conducted in the Ances Laboratory, focused on the early pathophysiological changes associated with preclinical Alzheimer’s disease using advanced neuroimaging tools. He went on to complete a residency in adult neurology at Barnes-Jewish Hospital, serving as Administrative Chief Resident, followed by specialized fellowship training in multiple sclerosis.
His research focuses on integrating magnetic resonance imaging (MRI) and positron emission tomography (PET) to better understand disease progression in multiple sclerosis. By combining imaging biomarkers with clinical data, Dr. Brier aims to identify early indicators of disease severity and uncover the biological mechanisms driving progression and disability in MS. His long-standing interest in brain structure-function relationships informs his cross-disciplinary work in neuroimmunology and neurodegeneration.
Dr. Brier has authored over 50 peer-reviewed publications and received the ASCI Emerging-Generation Award in 2023 in recognition of his contributions as a rising physician-scientist. He is a frequent speaker at national and international neurology meetings and maintains active collaborations across departments and institutions. His research continues to bridge clinical neurology and imaging science, with the goal of advancing precision medicine for patients with MS and related disorders.
Gerard Gianoli, MD, FACS | Neuro-otology
Consultant, Scientific Advisor
Gerard J. Gianoli, MD, FACS specializes in Neuro-otology and Skull Base Surgery. He graduated from Tulane University School of Engineering in 1982 and Tulane University School of Medicine in 1986. He did internships in Pediatrics and General Surgery before completing a residency in Otolaryngology-Head and Neck Surgery at Tulane University in 1992. After two years as an assistant professor at Tulane Medical School, he completed a fellowship in Neuro-otology and Skull Base Surgery at the Michigan Ear Institute in 1995. He then became a full-time associate professor at Tulane Medical School until he went into private practice in 2000.
He is currently in private practice at The Ear and Balance Institute, located in Covington, Louisiana and is also a Clinical Associate Professor in the Departments of Otolaryngology and Pediatrics at Tulane University School of Medicine. He pioneered treatments for Superior Semicircular Canal Dehiscence and other vestibular disorders. His private practice has a worldwide reach, with patient referrals coming from all over the United States, Canada, Europe, Asia and elsewhere. Dr. Gianoli was a major focus of the book “A Hole in My Life” (2016) by Philippa Thomson. He is editor of the textbook “Third Mobile Window Syndrome of the Inner Ear: Superior Semicircular Canal Dehiscence and Associated Disorders” (2022).
Dr. Gianoli practices all aspects of neuro-otology but has a special interest in vestibular (balance) disorders. He has researched, lectured, and published extensively on the topic of vestibular disorders, including evaluation of dizziness in the litigating patient and identification of malingering. He has published over 80 articles in peer-reviewed journals, has presented his research at more than 160 scientific meetings, and has been on multiple editorial review boards. He was the primary investigator for a NASA study that led to non-invasive intracranial pressure assessment to be used in the International Space Station.
Joshua Z. Goldenberg, ND, Dipl.FMS | Forensic Medical Sciences & Forensic Epidemiology
Director of Research, Forensic Consultant
Dr. Joshua Goldenberg is the Associate Director of the Helfgott Research Institute and an internationally recognized expert in evidence-based medicine. He holds a Bachelor of Science in Molecular Biology with honors and distinction from the University of Pennsylvania.
Dr. Goldenberg is an active researcher with numerous publications in leading scientific journals, including JAMA, Annals of Internal Medicine, and The Cochrane Library. His work on evidence-based medicine, research methodology, and probiotics has been presented nationally and internationally, and featured in major media outlets such as the BBC, The New York Times, The Seattle Times, Prevention Magazine, and Fox News.
He is a Diplomate in Forensic Medical Sciences and is currently pursuing a PhD in Forensic Epidemiology at Maastricht University under the mentorship of Dr. Michael Freeman, the founder of the field. He also formerly served as a Visiting Research Scholar at the University of Technology Sydney.
In addition, Dr. Goldenberg is a core faculty member for the Academy of Integrative Health and Medicine’s Inter-professional Fellowship, where he teaches critical appraisal and evidence-informed clinical decision-making.
Karen M. Parker, ND, MSCP, ABAAHP, FAARFM | Integrative Medicine, Perimenopausal/Menopausal Medicine
Co-founder, Clinician
Dr. Karen Parker is the co-founder of Neurevolution Medicine, PLLC. Dr. Parker's practice focuses on hormonal influences on female stress resilience, mood, cognition and interpersonal relationships. She provides individualized treatments related to hormonal health, peri- and post-menopausal and age-related cognitive changes, as well as endocrine, cardio-metabolic health and weight loss. She is also a nationally certified menopause provider by The Menopause Society.
Dr. Parker works in a collaborative care model which includes the disciplines of cardiology, endocrinology, gastroenterology, gynecology neuropsychology, psychiatry and sleep medicine.
For details about Dr. Parker’s integrative healthcare practice for Women please visit drkarenparker.com